Since some other mutations (eg, STK11 and KEAP1) are enriched in NSCLC and the KRASG12C mutation is also enriched in NSCLC, the association between these genes and KRASG12C may be caused by the coenrichment in NSCLC rather than a true association across all tumors. This evidence concerns the gene STK11 and non-small cell lung carcinoma.